Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Glioblastoma 39Breast Neoplasms 23Gliosarcoma 22Esophageal Neoplasms 21Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Pancreatic Neoplasms 15Squamous Cell Carcinoma of Head and Neck 13Rectal Neoplasms 13Brain Neoplasms 13Uterine Cervical Neoplasms 12Neoplasms 12Glioma 12Lung Neoplasms 11Head and Neck Neoplasms 11Melanoma 10Astrocytoma 10Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Central Nervous System Neoplasms 8Stomach Neoplasms 7Lymphoma, Follicular 6Esophageal Squamous Cell Carcinoma 6Endometrial Neoplasms 6Adenocarcinoma Of Esophagus 6Oropharyngeal Neoplasms 5Neoplasm Metastasis 5Lymphoma 5Carcinoma 5Rhabdomyosarcoma 4

Interventions

Capecitabine 4Radiation 3spartalizumab 2Oxaliplatin 2veliparib 1toripalimab 1tislelizumab 1sintilimab 1peposertib 1XELOX 1Radiotherapy 1Irinotecan 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Locally Advanced Rectal Cancer × Radiation × Clear all
NCT06493240 2025-11-25

NLCCRIT-LARC

Peking University People's Hospital

Phase 2 Completed
30 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT02605265 2025-08-28

CinClare

Fudan University

Phase 3 Completed
356 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT01589419 2017-11-20

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

AbbVie

Phase 1 Completed
32 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡